Biotech giant CSL says it has accelerated the manufacture of the AstraZeneca COVID-19 vaccine with the first doses planned for release in late March.
Biotech giant CSL says it has accelerated the manufacture of the AstraZeneca COVID-19 vaccine with the first doses planned for release in late March.